{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,10]],"date-time":"2025-12-10T08:25:08Z","timestamp":1765355108354,"version":"3.46.0"},"reference-count":32,"publisher":"American Medical Association (AMA)","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Netw Open"],"abstract":"\n Importance<\/jats:title>\n The interplay between sickle cell disease (SCD) and reproductive health remains understudied. Menstruation is particularly complex in individuals with SCD, who may have delayed puberty, early menopause, abnormal uterine bleeding, and overlapping SCD-related and menstruation-related pain.<\/jats:p>\n <\/jats:sec>\n \n Objective<\/jats:title>\n To assess menstrual patterns in female patients with SCD, these patients\u2019 access to and use of contraceptive therapy, and clinician practices associated with reproductive health.<\/jats:p>\n <\/jats:sec>\n \n Design, Setting, and Participants<\/jats:title>\n This cross-sectional survey study was conducted in 13 outpatient SCD centers across the US. Female patients with SCD who had reached menarche 12 or more months prior to enrollment between March 1, 2022, and May 31, 2024, and were not pregnant or post menopausal were included. Clinicians involved in the care of enrolled participants were also surveyed on a voluntary basis.<\/jats:p>\n <\/jats:sec>\n \n Main Outcomes and Measures<\/jats:title>\n Age-appropriate menstrual bleeding questionnaires were used to assess menstrual patterns, and global health was evaluated using the Patient-Reported Outcomes Measurement Information System mental and physical health scales. Newly designed patient-facing surveys were used to assessed SCD health and contraceptive use. Clinician-facing surveys assessed participants\u2019 clinical history and care plans after reviewing the patient surveys.<\/jats:p>\n <\/jats:sec>\n \n Results<\/jats:title>\n A total of 211 participants (mean [SD] age 23.7 [10.1] years) were enrolled. All patient-facing surveys with a corresponding clinician survey were completed for 183 participants (86.7%). Abnormal uterine bleeding was noted in 52 participants (24.6%) and was associated with a higher rate of hospitalizations (59.1% hospitalized in this group vs 34.5% in the non\u2013abnormal uterine bleeding group). Most participants (134 of 208 [64.4%]) endorsed sickle cell pain with menses. Among these participants, 42 (36.5%) had no emergency department (ED) visits, 51 (44.3%) had 1 to 3 ED visits, and 22 (19.1%) had 4 or more ED visits in the 6 months prior to enrollment compared with those who did not endorse sickle cell pain associated with menstruation (38 [58.5%], 24 [36.9%], and 3 [4.6%], respectively). In addition, among the participants who endorsed sickle cell pain, 57 (49.6%) had 0 hospitalizations, 48 (41.7%) had 1 to 3 hospitalizations, and 10 (8.7%) had 4 or more hospitalizations compared with those who did not endorse sickle cell pain associated with menstruation (50 [76.9%], 14 [21.5%], and 1 [1.5%], respectively). There was minimal use of hormonal contraception (40 of 208 participants [19.2%]), and 46 participants (22.1%) reported that they had never heard of these medications. After reviewing the patient survey, clinicians reported several intended steps to improve reproductive health for their patients, including reproductive health education (131 participants [72.4%]), referral to a reproductive health specialist (90 participants [49.7%]), or workup for iron deficiency (29 participants [16.0%]) or an underlying bleeding disorder (21 participants [11.6%]). Three participating sites established new multidisciplinary clinics for reproductive health and hematology during the enrollment period.<\/jats:p>\n <\/jats:sec>\n \n Conclusions and Relevance<\/jats:title>\n In this multicenter survey study of female individuals with SCD, sickle cell pain with menses was prevalent, and hormonal contraceptive use was low. The findings suggest that brief assessments may facilitate dialogue between female patients with SCD and their sickle cell clinicians and lay the groundwork for improved reproductive health and medical management.<\/jats:p>\n <\/jats:sec>","DOI":"10.1001\/jamanetworkopen.2025.46345","type":"journal-article","created":{"date-parts":[[2025,12,9]],"date-time":"2025-12-09T16:00:18Z","timestamp":1765296018000},"page":"e2546345","source":"Crossref","is-referenced-by-count":1,"title":["Role of Menstrual Bleeding Assessments in Sickle Cell Clinics"],"prefix":"10.1001","volume":"8","author":[{"given":"Gillian","family":"Rush","sequence":"first","affiliation":[{"name":"Division of Hematology, Department of Pediatrics, University of California, San Francisco"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rania E.","family":"Mohamed","sequence":"additional","affiliation":[{"name":"Division of Hematology, Department of Medicine, Duke University, Durham, North Carolina"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kimberly","family":"Moffatt-Bazile","sequence":"additional","affiliation":[{"name":"Division of Hematology, Department of Pediatrics, University of California, San Francisco"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sri Lakshmi","family":"Jamalapur","sequence":"additional","affiliation":[{"name":"Division of Hematology and Oncology, Department of Pediatrics, Children\u2019s Hospital of Michigan, Detroit"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gianna G.","family":"Valenti","sequence":"additional","affiliation":[{"name":"Division of Hematology and Oncology, Department of Pediatrics, Children\u2019s Hospital of Michigan, Detroit"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bindu K.","family":"Sathi","sequence":"additional","affiliation":[{"name":"Division of Hematology and Oncology, Department of Pediatrics, Valley Children\u2019s Hospital, Madera, California"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seethal","family":"Jacob","sequence":"additional","affiliation":[{"name":"Division of Hematology and Oncology, Department of Pediatrics, Riley Hospital for Children, Indianapolis, Indiana"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Layla N.","family":"Van Doren","sequence":"additional","affiliation":[{"name":"Division of Hematology, Department of Medicine, Yale University, New Haven, Connecticut"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria C.","family":"Velez","sequence":"additional","affiliation":[{"name":"Division of Hematology and Oncology, Department of Pediatrics, Manning Family Children\u2019s Hospital, Louisiana State University Health Sciences Center, Shreveport"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ugochi","family":"Ogu","sequence":"additional","affiliation":[{"name":"Division of Hematology and Oncology, Department of Medicine, University of Tennessee Health Science Center, Knoxville"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gayle M.","family":"Smink","sequence":"additional","affiliation":[{"name":"Division of Hematology and Oncology, Department of Pediatrics, Penn State University, Hershey, Pennsylvania"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Corinna L.","family":"Schultz","sequence":"additional","affiliation":[{"name":"Division of Hematology and Oncology, Department of Pediatrics, Nemours Children\u2019s Hospital, Wilmington, Delaware"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicole","family":"DiVirgilio","sequence":"additional","affiliation":[{"name":"Division of Hematology and Oncology, Department of Pediatrics, Nemours Children\u2019s Hospital, Wilmington, Delaware"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Esteban","family":"Gomez","sequence":"additional","affiliation":[{"name":"Division of Hematology and Oncology, Department of Pediatrics, Center for Inherited Blood Disorders, Orange, California"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maa-Ohui","family":"Quarmyne","sequence":"additional","affiliation":[{"name":"Division of Hematology and Oncology, Department of Pediatrics, Phoenix Children\u2019s Hospital, Phoenix, Arizona"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer","family":"Light","sequence":"additional","affiliation":[{"name":"Division of Hematology and Oncology, Department of Pediatrics, University of Illinois Peoria"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kalpna","family":"Gupta","sequence":"additional","affiliation":[{"name":"Division of Hematology and Oncology, Department of Medicine, University of California, Irvine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li","family":"Zhang","sequence":"additional","affiliation":[{"name":"Division of Hematology, Department of Pediatrics, University of California, San Francisco"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elliott P.","family":"Vichinsky","sequence":"additional","affiliation":[{"name":"Division of Hematology, Department of Pediatrics, University of California, San Francisco"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ward","family":"Hagar","sequence":"additional","affiliation":[{"name":"Division of Hematology, Department of Pediatrics, University of California, San Francisco"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angela","family":"Rivers","sequence":"additional","affiliation":[{"name":"Division of Hematology, Department of Pediatrics, University of California, San Francisco"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marsha","family":"Treadwell","sequence":"additional","affiliation":[{"name":"Division of Hematology, Department of Pediatrics, University of California, San Francisco"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John J.","family":"Strouse","sequence":"additional","affiliation":[{"name":"Division of Hematology, Department of Medicine, Duke University, Durham, North Carolina"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Neha","family":"Bhasin","sequence":"additional","affiliation":[{"name":"Division of Hematology, Department of Pediatrics, University of California, San Francisco"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"10","published-online":{"date-parts":[[2025,12,9]]},"reference":[{"issue":"8","key":"zoi251255r1","doi-asserted-by":"publisher","first-page":"e585","DOI":"10.1016\/S2352-3026(23)00118-7","article-title":"Global, regional, and national prevalence and mortality burden of sickle cell disease, 2000-2021: a systematic analysis from the Global Burden of Disease Study 2021.","volume":"10","author":"GBD 2021 Sickle Cell Disease Collaborators","year":"2023","journal-title":"Lancet Haematol"},{"key":"zoi251255r2","doi-asserted-by":"publisher","first-page":"S512","DOI":"10.1016\/j.amepre.2009.12.022","article-title":"Population estimates of sickle cell disease in the U.S.","volume":"38","author":"Hassell","year":"2010","journal-title":"Am J Prev Med"},{"issue":"4","key":"zoi251255r3","doi-asserted-by":"publisher","first-page":"255","DOI":"10.4103\/aam.aam_55_20","article-title":"Menstrual characteristics of sickle cell disease patients seen at a tertiary institution in North Western Nigeria.","volume":"20","author":"Mohammed-Durosinlorun","year":"2021","journal-title":"Ann Afr Med"},{"issue":"3","key":"zoi251255r4","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1002\/ajh.26818","article-title":"Pregnancy outcomes in women with sickle cell disease in California.","volume":"98","author":"Adesina","year":"2023","journal-title":"Am J Hematol"},{"issue":"2","key":"zoi251255r5","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1586\/17474086.2016.1126177","article-title":"Common gynecological challenges in adolescents with sickle cell disease.","volume":"9","author":"Stimpson","year":"2016","journal-title":"Expert Rev Hematol"},{"issue":"12","key":"zoi251255r6","doi-asserted-by":"publisher","first-page":"904","DOI":"10.2471\/BLT.23.291159","article-title":"Menstruation and sexual health, well-being and justice.","volume":"102","author":"Logie","year":"2024","journal-title":"Bull World Health Organ"},{"issue":"7","key":"zoi251255r7","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1016\/j.socscimed.2012.05.018","article-title":"African-American\/White differences in the age of menarche: accounting for the difference.","volume":"75","author":"Reagan","year":"2012","journal-title":"Soc Sci Med"},{"issue":"1","key":"zoi251255r9","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.30727","article-title":"Assessment of menstrual health in adolescent and young adults with sickle cell disease.","volume":"71","author":"Notice","year":"2024","journal-title":"Pediatr Blood Cancer"},{"issue":"1","key":"zoi251255r10","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1089\/whr.2019.0008","article-title":"Vaso-occlusive pain and menstruation in sickle cell disease: a focus group analysis.","volume":"1","author":"Day","year":"2020","journal-title":"Womens Health Rep (New Rochelle)"},{"issue":"12","key":"zoi251255r11","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.1089\/jwh.2023.0023","article-title":"Pain frequency and health care utilization patterns in women with sickle cell disease experiencing menstruation-associated pain crises.","volume":"32","author":"Segbefia","year":"2023","journal-title":"J Womens Health (Larchmt)"},{"issue":"2","key":"zoi251255r12","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1089\/jwh.2018.7147","article-title":"Acute vaso-occlusive pain is temporally associated with the onset of menstruation in women with sickle cell disease.","volume":"28","author":"Sharma","year":"2019","journal-title":"J Womens Health (Larchmt)"},{"issue":"1","key":"zoi251255r13","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1056\/NEJM199107043250103","article-title":"Pain in sickle cell disease. rates and risk factors.","volume":"325","author":"Platt","year":"1991","journal-title":"N Engl J Med"},{"issue":"5","key":"zoi251255r14","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1111\/1471-0528.13273","article-title":"The menstrual bleeding questionnaire: development and validation of a comprehensive patient-reported outcome instrument for heavy menstrual bleeding.","volume":"122","author":"Matteson","year":"2015","journal-title":"BJOG"},{"issue":"7","key":"zoi251255r15","doi-asserted-by":"publisher","DOI":"10.1002\/rth2.12615","article-title":"Quality of life in adolescents with heavy menstrual bleeding: validation of the Adolescent Menstrual Bleeding Questionnaire (aMBQ).","volume":"5","author":"Pike","year":"2021","journal-title":"Res Pract Thromb Haemost"},{"issue":"1","key":"zoi251255r16","doi-asserted-by":"publisher","DOI":"10.1590\/1516-3180.2022.0539.r2.100423","article-title":"Assessing a cut-off point for the diagnosis of abnormal uterine bleeding using the Menstrual Bleeding Questionnaire (MBQ): a validation and cultural translation study with Brazilian women.","volume":"142","author":"Rezende","year":"2023","journal-title":"Sao Paulo Med J"},{"issue":"7","key":"zoi251255r17","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1007\/s11136-009-9496-9","article-title":"Development of physical and mental health summary scores from the Patient-Reported Outcomes Measurement Information System (PROMIS) global items.","volume":"18","author":"Hays","year":"2009","journal-title":"Qual Life Res"},{"issue":"4","key":"zoi251255r18","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1002\/ajh.20485","article-title":"Medical care utilization and mortality in sickle cell disease: a population-based study.","volume":"80","author":"Shankar","year":"2005","journal-title":"Am J Hematol"},{"issue":"1","key":"zoi251255r19","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.clinthera.2024.09.023","article-title":"Clinical burden and health care resource utilization associated with managing sickle cell disease with recurrent vaso-occlusive crises in England.","volume":"47","author":"Udeze","year":"2025","journal-title":"Clin Ther"},{"issue":"10","key":"zoi251255r20","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0258638","article-title":"Sex-based differences in the manifestations and complications of sickle cell disease: report from the Sickle Cell Disease Implementation Consortium.","volume":"16","author":"Masese","year":"2021","journal-title":"PLoS One"},{"issue":"1","key":"zoi251255r21","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1542\/peds.111.1.110","article-title":"Age at menarche and racial comparisons in US girls.","volume":"111","author":"Chumlea","year":"2003","journal-title":"Pediatrics"},{"issue":"1-2","key":"zoi251255r22","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1515\/jpem-2013-0286","article-title":"Age of thelarche and menarche in contemporary US females: a cross-sectional analysis.","volume":"27","author":"Cabrera","year":"2014","journal-title":"J Pediatr Endocrinol Metab"},{"issue":"2","key":"zoi251255r23","doi-asserted-by":"publisher","first-page":"213.e1","DOI":"10.1016\/j.ajog.2022.10.029","article-title":"Abnormal uterine bleeding patterns determined through menstrual tracking among participants in the Apple Women\u2019s Health Study.","volume":"228","author":"Zhang","year":"2023","journal-title":"Am J Obstet Gynecol"},{"issue":"5","key":"zoi251255r24","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1016\/j.jnma.2021.05.005","article-title":"Women with sickle cell disease report low knowledge and use of long acting reversible contraception.","volume":"113","author":"Pecker","year":"2021","journal-title":"J Natl Med Assoc"},{"issue":"1","key":"zoi251255r25","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/s40834-025-00361-8","article-title":"Understanding and treating menstruation associated sickle cell pain.","volume":"10","author":"Olaniyan","year":"2025","journal-title":"Contracept Reprod Med"},{"issue":"1","key":"zoi251255r26","doi-asserted-by":"publisher","DOI":"10.4084\/mjhid.2020.032","article-title":"Current issues and options for hormonal contraception in adolescents and young adult women with sickle cell disease: an update for health care professionals.","volume":"12","author":"De Sanctis","year":"2020","journal-title":"Mediterr J Hematol Infect Dis"},{"issue":"20","key":"zoi251255r27","doi-asserted-by":"publisher","first-page":"6140","DOI":"10.1182\/bloodadvances.2023010204","article-title":"Comparison of thromboembolism outcomes in patients with sickle cell disease prescribed hormonal contraception.","volume":"7","author":"Bala","year":"2023","journal-title":"Blood Adv"},{"issue":"3","key":"zoi251255r28","first-page":"305","article-title":"Sickle cell disease.","volume":"377","author":"Piel","year":"2017","journal-title":"N Engl J Med"},{"key":"zoi251255r29","doi-asserted-by":"publisher","first-page":"75","DOI":"10.2147\/OAJC.S179673","article-title":"Venous thrombosis and hormonal contraception: what\u2019s new with estradiol-based hormonal contraceptives?","volume":"9","author":"Fruzzetti","year":"2018","journal-title":"Open Access J Contracept"},{"issue":"6","key":"zoi251255r30","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.31683","article-title":"How we approach contraception for adolescents and young adults with sickle cell disease.","volume":"72","author":"Leroy-Melamed","year":"2025","journal-title":"Pediatr Blood Cancer"},{"issue":"5","key":"zoi251255r31","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/S0010-7824(97)00156-X","article-title":"Effect of Depo-Provera or Microgynon on the painful crises of sickle cell anemia patients.","volume":"56","author":"de Abood","year":"1997","journal-title":"Contraception"},{"key":"zoi251255r32","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1186\/1477-7525-3-50","article-title":"Health related quality of life in sickle cell patients: the PiSCES project.","volume":"3","author":"McClish","year":"2005","journal-title":"Health Qual Life Outcomes"},{"year":"2023","author":"Farooqui","key":"zoi251255r8"}],"container-title":["JAMA Network Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/articlepdf\/2842565\/rush_2025_oi_251255_1764783098.73488.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,9]],"date-time":"2025-12-09T16:00:19Z","timestamp":1765296019000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/fullarticle\/2842565"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,9]]},"references-count":32,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2025,12,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2025.46345","relation":{},"ISSN":["2574-3805"],"issn-type":[{"type":"electronic","value":"2574-3805"}],"subject":[],"published":{"date-parts":[[2025,12,9]]}}}